We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Loews
L
$23.7B
| $7.26M | 0.02% |
122,500
-2,300
| -2% | -$145K |
|
752
Valvoline
VVV
$5.06B
| $7.21M | 0.02% |
250,000
+150,000
| +150% | +$4.61M |
|
753
MGE Energy Inc
MGEE
$3.01B
| $7.15M | 0.02% |
+91,923
| New | +$7.33M |
|
754
Federal Realty Investment Trust
FRT
$10.6B
| $7.12M | 0.02% |
74,400
-200
| -0.3% | -$22.5K |
|
755
Illumina
ILMN
$30.1B
| $7.12M | 0.02% |
39,688
-128,089
| -76% | -$32.7M |
|
|
AXNX
756
DELISTED
Axonics, Inc. Common Stock
AXNX
| $7.08M | 0.02% |
+125,000
| New | +$6.85M |
|
757
Vail Resorts
MTN
$5.32B
| $7.04M | 0.02% |
32,300
-7,500
| -19% | -$1.83M |
|
|
CHX
758
DELISTED
ChampionX
CHX
| $6.95M | 0.02% |
350,000
+100,000
| +40% | +$2.26M |
|
|
ATAQ
759
DELISTED
Altimar Acquisition Corp III
ATAQ
| $6.87M | 0.02% |
700,000
| – | – |
|
|
FSRX
760
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $6.86M | 0.02% |
700,000
| – | – |
|
761
UFP Industries
UFPI
$5.29B
| $6.81M | 0.02% |
100,000
| – | – |
|
762
Franklin Resources
BEN
$18.2B
| $6.8M | 0.02% |
291,600
-7,800
| -3% | -$199K |
|
|
SLN
763
Silence Therapeutics
SLN
$538M
| $6.7M | 0.02% |
565,000
+15,000
| +3% | +$182K |
|
|
EIGR
764
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $6.62M | 0.02% |
35,000
-21,667
| -38% | -$4.37M |
|
765
Hormel Foods
HRL
$13.9B
| $6.57M | 0.02% |
138,646
-285,500
| -67% | -$14.2M |
|
766
Brown-Forman Class B
BF.B
$13B
| $6.55M | 0.02% |
93,332
-97,500
| -51% | -$6.53M |
|
767
Tapestry
TPR
$31.6B
| $6.55M | 0.02% |
+214,548
| New | +$7.02M |
|
768
Clorox
CLX
$12.5B
| $6.54M | 0.02% |
46,400
-82,053
| -64% | -$11.7M |
|
769
Mammoth Energy Services
TUSK
$135M
| $6.42M | 0.01% |
+2,918,123
| New | +$6.54M |
|
770
News Corp Class A
NWSA
$15.3B
| $6.3M | 0.01% |
404,610
-3,600
| -0.9% | -$66.2K |
|
771
Wynn Resorts
WYNN
$10.1B
| $6.26M | 0.01% |
109,900
-2,300
| -2% | -$152K |
|
772
Lamb Weston
LW
$7.28B
| $6.17M | 0.01% |
86,400
-65,200
| -43% | -$4.31M |
|
773
SunCoke Energy
SXC
$754M
| $6.13M | 0.01% |
+900,000
| New | +$7.26M |
|
|
SOGU
774
DELISTED
AXS Short De-SPAC Daily ETF
SOGU
| $6.12M | 0.01% |
92,000
-66,000
| -42% | -$3.2M |
|
|
MRNS
775
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $6.11M | 0.01% |
1,262,500
| – | – |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.